Monitoring the birth of an industry
By Gregg A. Masters, MPH It’s interesting to note the more ‘things change’, the more they ‘[seem] to stay the same?’ Let me explain…. In a recent observation by Rob Lazerow featured in the post ‘How Are ACOs Doing‘ the Advisory Board Senior Consultant dubs 2013 as the ‘year of accountable care’. He then goes …
Continue reading “So What’s with the [ACO] Bundled Payment Thing?”
This post originally appeared at HealthHombre. The national health expenditure data released last week showed relatively modest 2011 growth, which promptly provoked a back-and-forth about what the figures truly say and what they portend for holding spending in check going forward. Amid considerable mental gear gnashing, the data have been assessed in light of such potential cost influencers as lingering recessionary effects, clinical v. administrative drivers, and imminent arrival of the full-bore ACA. Occupying several nodes along the public-opinion continuum, headlines ranged from “Spending …
Continue reading “Signal to Noise Challenges in ACO Actuarial Data: Who’s ‘At Greater Risk?’”
By Gregg A. Masters, MPH In the realm of stuff we need to do and sometimes clouded by either ad copy or less than straightforward guru guidance cutting through the clutter can sometimes be confused by the words ‘may’, ‘should’ or other less obligatory statements. For instance: M/U/S/T | a verb |to: be commanded or …
Continue reading “‘The ACO Must…’ Towards an Operational Definition of ‘Patient Engagement’”
By Gregg A. Masters, MPH The 31st annual get together of biotech, pharma and an eclectic litany of publically held healthcare company and many impressive tax exempt health system peeps was my first albeit from a somewhat disadvantaged, i.e., ‘crasher’, status. Yet, in the overall program mix there seemed to be something for everybody from …
Continue reading “JP Morgan Healthcare Conference Unbundled: Something for Everyone?”
By Gregg A. Masters, MPH Industry watchers have to be impressed by the announcement from CMS today that effectively doubles the ACO count from prior reported totals. Is it just me, or can you can sense the subtle shift in market sentiment from skepticism to loss of first mover opportunity in one’s market. For the list of …
Continue reading “And the Circle Grows! CMS Announces Another Round of ACOs”
By Gregg A. Masters, MPH The ‘signal to noise’ discernment premium went up a notch recently with the following tweet: @NCQA Read more about newly recognized ACO @KelseySeybold and their commitment to quality and value in the Houston Chronicle http://ow.ly/g6vzl 7:39 AM – 14 Dec 12 And with that breaking news announcement (Kelsey Seybold is …
Continue reading “More or Less Confusion in ACO World: Who Really ‘Certifies’ ACOs?”
November 27th, 2012 [Editor’s note: portions of broadcast present with low audio]. NEHI Summit Explores Innovations In the Emerging ACO Landscape The opportunities – and the challenges – presented by the rapid movement towards Accountable Care Organizations were the subject of a recent NEHI summit that drew perspectives from across health care: “I think ACOs …
Continue reading “New England Healthcare Institute (NEHI) ACO Innovation Summit”
By Gregg A. Masters, MPH From Leavitt Partners. a webinar held on November 8th, 2012. The focus is on ACOs, and represents an update post elections from their previous reporting here.
By Gregg A. Masters, MPH Last Friday I moderated the HealthIT social media focused tweetchat tagged ‘#HITsm’, see context piece here, and transcript here. The theme centered on the value or centrality of HealthIT to ACO success. The conversation was lively (for additional context, ACO surprise provides metrics on dispersion and penetration into Medicare and commercial markets), and …
Continue reading “A/C/O: ‘Another Compromised Organization’ or ‘A Coordinated Orchestra?’”
By Gregg A. Masters, MPH Timing can be everything at times, no? Just after completing the post: ‘From “Unicorns to Multicorns” ACOs Morphing Below Radar‘, I received information from Oliver Wyman, a Marsh McLennan Company, previewing a study which documents (at least for some) ‘unexpected’ results in the world of ACO penetration. For background market …
acowatch.me 